response

Open Access
First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease
MOTOKAZU SATO, QINGHONG HAN, CHIHIRO HOZUMI, HIDEO KUJIRAOKA, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research September 2024, 44 (9) 3885-3889; DOI: https://doi.org/10.21873/anticanres.17215
You have access
Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification
YE MA, XIANXIAN LIANG, LI LIU, DAZHI GAO, TAO YANG, ROBERT M. HOFFMAN and JIAN XU

Anticancer Research November 2021, 41 (11) 5507-5515; DOI: https://doi.org/10.21873/anticanres.15364
You have access
Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
TETSUYA YUMIOKA, MASASHI HONDA, RYUTARO SHIMIZU, SHOGO TERAOKA, NORIYA YAMAGUCHI, BUNYA KAWAMOTO, HIDETO IWAMOTO, SHUICHI MORIZANE, KATSUYA HIKITA and ATSUSHI TAKENAKA

Anticancer Research November 2021, 41 (11) 5767-5773; DOI: https://doi.org/10.21873/anticanres.15393
Open Access
Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase
QINGHONG HAN and ROBERT M. HOFFMAN

Anticancer Research April 2021, 41 (4) 1921-1926; DOI: https://doi.org/10.21873/anticanres.14958
You have access
Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage
MAKOTO SOHDA, TATSUYA MIYAZAKI, MAKOTO SAKAI, YUJI KUMAKURA, HIROAKI HONJYO, KEIGO HARA, NARITAKA TANAKA, TAKEHIKO YOKOBORI and KEN SHIRABE

Anticancer Research June 2019, 39 (6) 3167-3175; DOI: https://doi.org/10.21873/anticanres.13454
You have access
Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer
DIRK RADES, ANNIKA PANZNER, STEFAN JANSSEN, JUERGEN DUNST, THEO VENINGA, NIELS H. HOLLÄNDER and STEVEN E. SCHILD

Anticancer Research December 2018, 38 (12) 6897-6903; DOI: https://doi.org/10.21873/anticanres.13066
You have access
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience
ANDREA SBRANA, ELISA BIASCO, FEDERICO PAOLIERI, ERICA PALESANDRO, CLAUDIA CASERTA, ROBERTO IACOVELLI, BEATRICE DETTI, DANIELE SANTINI, ALESSANDRA MOSCA, FRANCO MORELLI, GIUSEPPE FORNARINI, UGO DE GIORGI, CRISTINA MASINI and LUCA GALLI

Anticancer Research August 2018, 38 (8) 4913-4918; DOI: https://doi.org/10.21873/anticanres.12807
You have access
Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients
ALEXANDR POPRACH, ONDREJ FIALA, RENATA CHLOUPKOVA, BOHUSLAV MELICHAR, RADEK LAKOMY, KATARINA PETRAKOVA, MILADA ZEMANOVA, KATERINA KOPECKOVA, ONDREJ SLABY, HANA STUDENTOVA, JINDRICH KOPECKÝ, IGOR KISS, JINDRICH FINEK, LADISLAV DUSEK and TOMAS BUCHLER

Anticancer Research January 2018, 38 (1) 449-456;
You have access
Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults
SHINSUKE SASADA, MAKOTO KODAIRA, TATSUNORI SHIMOI, AKIHIKO SHIMOMURA, MAYU YUNOKAWA, KAN YONEMORI, CHIKAKO SHIMIZU, YASUHIRO FUJIWARA and KENJI TAMURA

Anticancer Research May 2016, 36 (5) 2429-2432;
You have access
The Role of Interim ¹⁸F-FDG PET/CT in Predicting Early Response to Neoadjuvant Chemotherapy in Breast Cancer
KISOO PAHK, SEUNGHONG RHEE, JAEHYUK CHO, MINHEE SEO, SINAE LEE, TAEGYU PARK, SOYEON PARK, EUNSUB LEE, KYUNG HWA PARK, CHULHAN KIM, JAE SEON EO, SUNGEUN KIM and JAE GOL CHOE

Anticancer Research August 2014, 34 (8) 4447-4455;

Main menu

User menu

Search

response

Pages